1. Home
  2. TARS vs STC Comparison

TARS vs STC Comparison

Compare TARS & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • STC
  • Stock Information
  • Founded
  • TARS 2016
  • STC 1893
  • Country
  • TARS United States
  • STC United States
  • Employees
  • TARS N/A
  • STC N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • STC Specialty Insurers
  • Sector
  • TARS Health Care
  • STC Finance
  • Exchange
  • TARS Nasdaq
  • STC Nasdaq
  • Market Cap
  • TARS 2.0B
  • STC 2.0B
  • IPO Year
  • TARS 2020
  • STC N/A
  • Fundamental
  • Price
  • TARS $47.84
  • STC $68.95
  • Analyst Decision
  • TARS Strong Buy
  • STC Buy
  • Analyst Count
  • TARS 6
  • STC 3
  • Target Price
  • TARS $56.00
  • STC $77.67
  • AVG Volume (30 Days)
  • TARS 460.8K
  • STC 161.7K
  • Earning Date
  • TARS 02-25-2025
  • STC 02-05-2025
  • Dividend Yield
  • TARS N/A
  • STC 2.90%
  • EPS Growth
  • TARS N/A
  • STC 134.79
  • EPS
  • TARS N/A
  • STC 2.61
  • Revenue
  • TARS $129,621,000.00
  • STC $2,488,819,000.00
  • Revenue This Year
  • TARS $921.89
  • STC N/A
  • Revenue Next Year
  • TARS $85.83
  • STC $12.55
  • P/E Ratio
  • TARS N/A
  • STC $26.46
  • Revenue Growth
  • TARS 801.96
  • STC 10.14
  • 52 Week Low
  • TARS $20.08
  • STC $58.23
  • 52 Week High
  • TARS $57.28
  • STC $78.44
  • Technical
  • Relative Strength Index (RSI)
  • TARS 39.21
  • STC 59.79
  • Support Level
  • TARS $49.86
  • STC $67.41
  • Resistance Level
  • TARS $53.22
  • STC $68.91
  • Average True Range (ATR)
  • TARS 2.44
  • STC 1.61
  • MACD
  • TARS -0.56
  • STC 0.39
  • Stochastic Oscillator
  • TARS 7.09
  • STC 90.59

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: